Haas Jason (CIK 1883821) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy LGND (6,138 shares), Sell LGND (7,138 shares), Buy LGND (3,000 shares), Buy LGND (1,000 shares), Sell LGND (3,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 6,138 | $316,475 |
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Sell | 7,138 | $2.1M |
| 2026-06-15 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 3,000 | $154,680 |
| 2026-06-15 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 1,000 | $51,560 |
| 2026-06-15 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Sell | 3,000 | $765,034 |
| 2026-06-15 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Sell | 3,461 | $886,286 |
| 2026-06-09 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 836 | $0 |
| 2026-05-11 | Odyssey Therapeutics, Inc. (ODTX) | Chief Financial Officer | Buy | 1,000 | $20,000 |
| 2025-06-10 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 1,209 | $0 |
Source: SEC Form 4 filings · as of 2026-08-14